Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation

• Publication date

  2010-08-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.110.940619PMID 20660803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2012cited by this paper
• Defibrillator implantation early after myocardial infarction.

  2009cited by this paper
• Legal regulations of pathology in Russia

  2008cited by this paper
• Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators

  2007cited by this paper
• Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.

  2005cited by this paper
• Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.

  2005cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

  2004cited by this paper
• Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

  2004cited by this paper
• Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction

  2004cited by this paper
• Acute ischaemia as a trigger of sudden cardiac death

  2004cited by this paper
• Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era.

  2003cited by this paper
• Acute myocardial infarction

  2003cited by this paper
• Acute myocardial infarction.

  2003cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• How do heart failure patients die

  2002cited by this paper
• Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

  2002cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease.

  2002cited by this paper
• Sudden cardiac death.

  2001cited by this paper
• Sudden Cardiac Death in the United States, 1989 to 1998

  2001cited by this paper
• Sudden death due to cardiac arrhythmias.

  2001cited by this paper
• Task Force on Sudden Cardiac Death of the European Society of Cardiology.

  2001cited by this paper
• Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations.

  2000cited by this paper
• Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations].

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Cardiovascular disease in the Netherlands, 1975 to 1995: decline in mortality, but increasing numbers of patients with chronic conditions

  1999cited by this paper
• Sudden cardiac death.

  1998cited by this paper
• Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) trials.

  1997cited by this paper
• Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials.

  1996cited by this paper
• Mode of death in chronic heart failure. A request and proposition for more accurate classification.

  1996cited by this paper
• Sudden cardiac death. Structure, function, and time-dependence of risk.

  1992cited by this paper
• Sudden cardiac death.

  1987cited by this paper
• Risk factors for sudden death after acute myocardial infarction: two-year follow-up.

  1984cited by this paper
• The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

  1984cited by this paper
• Survivorship patterns in the posthospital phase of myocardial infarction.

  1979cited by this paper

• Deep Learning-Based Risk Assessment and Prediction of Cardiac Outcomes Using Single-Lead 24-Hour Holter-ECG in Patients with Heart Failure or Myocardial Infarction

  2025cites this paper
• Sudden Cardiac Death-Etiology, Risk Factors and Demographic Characteristics: An Extensive Study of 1618 Forensic Autopsies

  2024influential citation
• Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.

  2024cites this paper
• 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

  2024cites this paper
• Refining the stratification of sudden cardiac death risk after myocardial infarction-beyond ejection fraction.

  2024cites this paper
• Mechanism of Ventricular Tachycardia Occurring in Chronic Myocardial Infarction Scar.

  2024cites this paper
• Unsupervised Stratification of Patients With Myocardial Infarction Based on Imaging and In-Silico Biomarkers

  2024cites this paper
• Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.

  2024cites this paper
• Electrically Conductive Collagen‐PEDOT:PSS Hydrogel Prevents Post‐Infarct Cardiac Arrhythmia and Supports hiPSC‐Cardiomyocyte Function

  2024cites this paper
• HF Etiology and cardiac contractility modulation therapy

  2024cites this paper
• The role of m6A modification in cardiovascular disease: A systematic review and integrative analysis.

  2024cites this paper
• Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

  2023cites this paper
• Cardiac-specific deletion of BRG1 ameliorates ventricular arrhythmia in mice with myocardial infarction

  2023cites this paper
• Sudden Cardiac Death in Ischaemic Cardiomyopathy and the Primary Prevention ICD: Time for a More a Personalised Approach?

  2023cites this paper
• Ischemia-reperfusion myocardial infarction induces remodeling of left cardiac-projecting stellate ganglia neurons.

  2023cites this paper
• Loss of chondroitin sulfate proteoglycan sulfation allows delayed sympathetic reinnervation after cardiac ischemia–reperfusion

  2023cites this paper
• ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction

  2023cites this paper
• When Flatliners Meet the Wearable Cardioverter-Defibrillator.

  2023cites this paper
• Knockout of ACE-N facilitates improved cardiac function after myocardial infarction

  2022cites this paper
• Heart Failure Burden by Autopsy, Guideline-Directed Medical Therapy, and ICD Utilization Among Sudden Deaths.

  2022cites this paper
• Risk factors for sudden cardiac arrest in patients with ST-segment elevation myocardial infarction: a retrospective cohort study

  2022cites this paper
• ADAM15 is required for optimal collagen cross-linking and scar formation following myocardial infarction.

  2022cites this paper
• Maternal sudden death: A nationwide retrospective study

  2022cites this paper
• Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?

  2022cites this paper
• Clinicopathological correlates of out‐of‐hospital cardiac arrests

  2022cites this paper
• Primary Prevention ICD Therapy in Heart Failure with Recovered Ejection Fraction.

  2021cites this paper
• JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias

  2021cites this paper
• Reply: Presumed Sudden Cardiac Deaths in the PARADIGM-HF Trial.

  2021cites this paper
• Fibroblast Growth Factor 21 Ameliorates NaV1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes

  2021cites this paper
• Sudden cardiac death

  2021cites this paper
• JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.

  2021cites this paper
• One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction

  2021cites this paper
• Association between T wave morphology parameters and abnormal cardiac SPECT imaging.

  2021cites this paper
• Yangxinkang tablet protects against cardiac dysfunction and remodelling after myocardial infarction in rats through inhibition of AMPK/mTOR-mediated autophagy

  2020cites this paper
• Myocardial cathepsin D is downregulated in sudden cardiac death

  2020cites this paper
• Sudden death prevention post-myocardial infarction and after VEST.

  2020cites this paper
• Sudden cardiac death after myocardial infarction

  2020cites this paper
• Early Post-Infarction Survival in the Modern Era: Reinforcing Old Lessons.

  2020cites this paper
• Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study

  2020cites this paper
• Circulating Circular RNAs: Novel Biomarkers for Heart Failure

  2020cites this paper
• Free Wall Myocardial Rupture and Ventricular Septal Defect in an Ambulatory Patient

  2020cites this paper
• The Human Explanted Heart Program: A translational bridge for cardiovascular medicine

  2020cites this paper
• Impact of wearable cardioverter‐defibrillator compliance on outcomes in the VEST trial: As‐treated and per‐protocol analyses

  2020cites this paper
• Noninvasive Risk Stratification for Sudden Cardiac Death

  2020cites this paper
• Tragbarer Kardioverter-Defibrillator nach Myokardinfarkt: Keine signifikante Reduktion des plötzlichen Herztods

  2019cites this paper
• Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non‐sudden cardiac death in myocardial infarction survivors with heart failure

  2019cites this paper
• Non-arrhythmic causes of sudden death: A comprehensive review.

  2019cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice.

  2019influential citation
• Draft 1 AC-SDKP treatment protects heart against excessive myocardial injury and heart failure in mice

  2019cites this paper
• Predictors of arrhythmias, cardiac arrest, and mortality in acute coronary syndrome

  2019cites this paper
• The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia.

  2019cites this paper
• Sudden Death Risk-Stratification in 2018-2019: The Old and the New.

  2019cites this paper
• Toll-like Receptor 7 Deficiency Promotes Survival and Reduces Adverse Left Ventricular Remodeling After Myocardial Infarction.

  2019cites this paper
• Patienten mit einer tragbaren Defibrillatorweste („wearable cardioverter-defibrillator“, WCD)

  2019cites this paper
• Rad GTPase Deletion Attenuates Post-Ischemic Cardiac Dysfunction and Remodeling

  2018cites this paper
• Cardiovascular Magnetic Resonance in Acute ST-Segment–Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions

  2018cites this paper
• Prevalence and pattern of cardiovascular-related causes of out-of- hospital deaths in Lagos, Nigeria

  2018cites this paper
• Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial.

  2018cites this paper
• Clinical Usefulness of Wearable Cardioverter Defibrillator (WCD) and Current Understanding of Its Clinical Indication in Japan.

  2018cites this paper
• Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials

  2018cites this paper
• The wearable cardioverter defibrillator: Still without a compelling indication

  2018cites this paper
• Ectopic beats arise from micro-reentries near infarct regions in simulations of a patient-specific heart model

  2018cites this paper
• Risk Stratification of Sudden Cardiac Death After Acute Myocardial Infarction

  2018cites this paper
• Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury

  2018cites this paper
• Optimal Strategies for Mitigating Sudden Cardiac Death Risk in At-risk Patients with Structural Heart Disease

  2018cites this paper
• Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry

  2018cites this paper
• Modulation of NFKB1/p50 by ROS leads to impaired ATP production during MI compared to cardiac hypertrophy

  2018cites this paper
• Gender Differences in Ischemic Cardiomyopathy

  2018cites this paper
• Considerazioni su una valutazione poliparametrica nella stratificazione del rischio di morte improvvisa per l’indicazione all’impianto di cardioverter-defibrillatore in prevenzione primaria, nella disfunzione ventricolare

  2018cites this paper
• Wearable Cardioverter–Defibrillator after Myocardial Infarction

  2018cites this paper
• Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death: POST SCD Study

  2018cites this paper
• Killing Many Birds With Two Stones: Hypoxia and Fibrosis Can Generate Ectopic Beats in a Human Ventricular Model

  2018cites this paper
• Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.

  2018cites this paper
• Prevention of sudden cardiac death after revascularization for coronary heart disease

  2018cites this paper
• Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death

  2017cites this paper
• Sudden Cardiac Death in Ischemic Heart Disease: Pathophysiology and Risk Stratification.

  2017cites this paper
• Death with an implantable cardioverter-defibrillator: a MADIT-II substudy.

  2017cites this paper
• Positionspapier zum Einsatz des tragbaren Kardioverter-Defibrillators // Wearable cardioverter-defibrillator – A Review

  2017cites this paper
• 22 – Prevention of Sudden Cardiac Death

  2017cites this paper
• Development and validation of clinical risk score to predict the cardiac rupture in patients with STEMI☆

  2017cites this paper
• Sex and Gender Specific Aspects—From Cells to Cardiovascular Disease

  2017cites this paper
• Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter–Defibrillator Failure and Currently Available Options

  2017cites this paper
• The effects of sacubitril/valsartan on coronary outcomes in PARADIGM‐HF

  2017cites this paper
• Coronary ischemia: Global trigger of sudden cardiac death.

  2017cites this paper
• Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned?

  2017cites this paper
• Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?

  2017cites this paper
• Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies

  2016cites this paper
• Indications and use of the wearable cardiac defibrillator

  2016cites this paper
• Effet de mesures hygiéno-diététiques reposant sur l'exercice physique couplé à une diète alimentaire sur la fonction régionale myocardique droite et gauche dans le syndrome métabolique

  2016cites this paper
• Pharmacological interventions for heart failure in people with chronic kidney disease.

  2016cites this paper
• The epidemiology of sudden cardiac death in Western Australia

  2016influential citation
• Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association

  2016cites this paper
• Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance

  2016cites this paper
• Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association

  2016cites this paper
• Frequency and Implications of Ischemia Prior to Ventricular Tachyarrhythmia in Patients Treated With a Wearable Cardioverter Defibrillator Following Myocardial Infarction

  2016cites this paper
• Diabetes mellitus, high BMI and low education level predict sudden cardiac death within 24 hours of incident myocardial infarction

  2016cites this paper
• Toll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation.

  2016cites this paper
• Genetic markers of repolarization and arrhythmic events after acute coronary syndromes.

  2015cites this paper
• The spectrum of epidemiology underlying sudden cardiac death.

  2015cites this paper
• Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.

  2015cites this paper